Palbociclib Breast Cancer Drug May Be Effective Against Other Types Of Cancer
Palbociclib, a new oral drug with efficacy in combating breast cancer both alone and in combination with endocrine therapy, also has potential to combat other types of cancer, according to a literature review and additional research in JAMA Oncology.
Palbociclib targets the rapid division of tumor cells by inhibiting the activity of the enzymes CDK4 and CDK6, which propel cell division and increase in number in most cancers. It is the first CDK4/6 inhibitor to be approved for the treatment of breast cancer.
"All living cells undergo cell division and palbociclib's unique capacity to halt the…